|
|
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date25 Apr 1977 |
100 Clinical Results associated with Nantong Senxuan Pharmaceutical Co. Ltd.
0 Patents (Medical) associated with Nantong Senxuan Pharmaceutical Co. Ltd.
100 Deals associated with Nantong Senxuan Pharmaceutical Co. Ltd.
100 Translational Medicine associated with Nantong Senxuan Pharmaceutical Co. Ltd.